Messenger RNA

Internal medicine

Disease

Severe acute respiratory syndrome coronavirus

Coronavirus disease 2019 (COVID-19)

Infectious disease (medical specialty)

Biology

Gene

Outbreak

Virology

Coronavirus

2019-20 coronavirus outbreak

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Biochemistry

Medicine

New England Journal of Medicine

Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions.

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines